Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome: Use of dual marker labeling to monitor therapeutic response

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 17, Issue 3, 1994, Pages 255-263

  Vonderheid, E C ^a   Bigler, R D ^a   Greenberg, A S ^a   Neukum, S J ^a   Micaily, B ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; MEMBRANE ANTIGEN; METHOXSALEN; RECOMBINANT ALPHA2B INTERFERON; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; PUVA; SEZARY SYNDROME; T LYMPHOCYTE;

EID: 0028231885     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199406000-00016     Document Type: Article

References (0)